Prognostic factors of brain metastases from colorectal cancer

[1]  Y. Kanemitsu,et al.  Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study , 2019, Annals of Surgical Oncology.

[2]  Bei Zhang,et al.  Brain metastases in newly diagnosed colorectal cancer: a population-based study , 2018, Cancer management and research.

[3]  K. Sugiyama,et al.  Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Y. Kanemitsu,et al.  Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan , 2018, BMC Cancer.

[5]  Y. Kanemitsu,et al.  Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis , 2018, Annals of Surgical Oncology.

[6]  P. Brown,et al.  Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Ishihara,et al.  Brain Metastasis from Colorectal Cancer: Predictors and Treatment Outcomes , 2017, Oncology.

[8]  J. Kleeff,et al.  Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors. , 2015, Clinical colorectal cancer.

[9]  C. Nieder,et al.  Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  A. Akabane,et al.  Stereotactic radiosurgery for patients with brain metastases - authors' reply. , 2014, The Lancet Oncology.

[11]  G. Honda,et al.  Prognostic Factors and Treatment Effects in Patients With Curatively Resected Brain Metastasis From Colorectal Cancer , 2014, Diseases of the colon and rectum.

[12]  P. Brown,et al.  Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. , 2012, Journal of neurosurgery.

[13]  M. Yano,et al.  Brain metastasis from colorectal cancer: Prognostic factors and survival , 2012, Journal of surgical oncology.

[14]  H. Geinitz,et al.  Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[15]  M. McDermott,et al.  Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[16]  Xianghua Luo,et al.  Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Brown,et al.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.

[18]  T. Tosteson,et al.  Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. , 2009, Clinical colorectal cancer.

[19]  A. Piga,et al.  Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases , 2009, Journal of Cancer Research and Clinical Oncology.

[20]  S. Bartelt,et al.  Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival. , 2004, World journal of gastroenterology.

[21]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[23]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[24]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[25]  D. Nelson,et al.  Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. , 1989, International journal of radiation oncology, biology, physics.

[26]  L. Laliberte,et al.  The Karnofsky performance status scale: An examination of its reliability and validity in a research setting , 1984, Cancer.

[27]  P. Ganz,et al.  Karnofsky performance status revisited: reliability, validity, and guidelines. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Rushikesh S. Joshi,et al.  Prognostic Importance of Cumulative Intracranial Tumor Volume in Patients with Gastrointestinal Brain Metastasis Treated with Stereotactic Radiosurgery. , 2019, World neurosurgery.

[29]  Jong-Hee Chang,et al.  Brain metastases from colorectal carcinoma: prognostic factors and outcome , 2010, Journal of Neuro-Oncology.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  W Curran,et al.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.